About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Cystic Fibrosis Earns a New Bacterial Foe

by Tanya Thomas on October 4, 2010 at 11:07 AM
Font : A-A+

 Cystic Fibrosis Earns a New Bacterial Foe

Measuring the health status of cystic fibrosis (CF) patients would now get easier as researchers have found that exacerbations in CF are linked to chronic infection with a bacterium called Stenotrophomonas maltophilia.

The finding that chronic infection with S. maltophilia is independently linked with an increased risk of exacerbations gives clinicians and researchers a new potential target in fighting their disease as well.

Advertisement

"Our study showed that chronic infection with S. maltophilia, which was previously not regarded as prognostically significant, may have a real impact on the progression of CF in patients," said Valerie Waters of the Hospital for Sick Children in Toronto.

To assess whether S. maltophilia represented a true infection, rather than merely a colonizing organism, and whether it had an impact on the progression of disease, Waters and colleagues performed a two-stage study.
Advertisement

In the first stage, they sought to determine if S. maltophilia generated an immune response in CF patients.

In the second stage, they retrospectively followed almost 700 CF patients for 12 years to determine whether chronic infection with S. maltophilia was independently associated with an increased risk of exacerbation or lowered lung function.

They found that antibody levels to S. maltophilia flagellin, were about two times higher in chronically infected patients compared to those who were never infected, indicating a specific immune response and a true infection, rather than mere colonization.

The increased antibody levels were also associated with lower lung function, as measured by FEV1 (forced expiratory volume in one second.)

Furthermore, they found that patients with chronic S. maltophilia infections had a 63 percent greater risk of exacerbations than those who had never been infected, although there were no significant differences detected in the rate of lung function decline.

"It is crucial that we look to determine whether chronic S. maltophilia infection directly results in the worsening of lung function.

"We plan to investigate the effects of chronic S. maltophilia during pulmonary exacerbations in future studies," said Waters.

The findings were published online in the American Journal of Respiratory and Critical Care Medicine.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test  Your Knowledge on Heart
Test Your Knowlege on Genes
Obesity in Teens Make Inroads into Early Atrial Fibrillation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Genetic Testing of Diseases Cystic Fibrosis Fibroscan for Fatty Liver Cirrhosis and Fibrosis Retroperitoneal Fibrosis / Ormondīs Disease 

Most Popular on Medindia

Noscaphene (Noscapine) Find a Hospital Post-Nasal Drip Selfie Addiction Calculator Drug - Food Interactions Indian Medical Journals A-Z Drug Brands in India Drug Interaction Checker Nutam (400mg) (Piracetam) Loram (2 mg) (Lorazepam)
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Cystic Fibrosis Earns a New Bacterial Foe Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests